DexCom, Inc. (NASDAQ:DXCM) today announced that management will present
an update on DexCom at the following upcoming investor conferences:
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization of the company's products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company's development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company's
quarterly report on Form 10-K for the fiscal year ended December 31,
2013, as filed with the Securities and Exchange Commission on February
[ Back To NFVZone's Homepage ]